Order Article Reprints

Remmerts de Vries IF, Ronden MI, Bahce I, Spoelstra FOB, De Haan PF, Haasbeek CJA, Lissenberg-Witte BI, Slotman BJ, Dahele M, Verbakel WFAR. Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer. Cancers. 2021; 13(23):5923. https://doi.org/10.3390/cancers13235923

Remmerts de Vries, Isabel F., Merle I. Ronden, Idris Bahce, Femke O. B. Spoelstra, Patricia F. De Haan, Cornelis J. A. Haasbeek, Birgit I. Lissenberg-Witte, Ben J. Slotman, Max Dahele, and Wilko F. A. R. Verbakel. 2021. "Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer" Cancers 13, no. 23: 5923. https://doi.org/10.3390/cancers13235923

Remmerts de Vries, I. F., Ronden, M. I., Bahce, I., Spoelstra, F. O. B., De Haan, P. F., Haasbeek, C. J. A., Lissenberg-Witte, B. I., Slotman, B. J., Dahele, M., & Verbakel, W. F. A. R. (2021). Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer. Cancers, 13(23), 5923. https://doi.org/10.3390/cancers13235923